InvestorPlace - Stock Market News, Stock Advice & Trading Tips
AeroClean (NASDAQ:AERC) stock is getting a great deal of attention from investors after the company yesterday disclosed that the Food and Drug Administration (FDA) has designated its air purification system as a "Class II Medical Device." AERC stock soared 100% yesterday, but it has fallen over 15% in early trading today.
AeroClean's air purification device, the Purgo, is "proven to eliminate 99.99% of harmful airborne microorganisms, including bacteria, fungi and viruses, like COVID-19," AeroClean explained. The company noted that it sells "air purification and air sanitization technology" to "healthcare facilities, businesses, hospitality venues and government agencies."
Despite the huge rally of AERC stock yesterday, the shares are still changing hands for less than 4% of the name's 52-week high of $117. Also notable is that AeroClean has an enterprise value of $19.5 million, according to Yahoo Finance.
On the other hand, in all of last year, the company only generated $600,000 of revenue. And has a negative earnings-per-share (EPS) of 0.69.
In the last five days, the shares have jumped 88%, but they have tumbled 60% so far this year. AERC stock currently sits in penny stock territory at around $4 a share.
On the date of publication, Larry Ramer did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That's because these "penny stocks" are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com's writers disclose this fact and warn readers of the risks.
Read More: Penny Stocks — How to Profit Without Getting Scammed
The post AERC Stock Is in the Spotlight After AeroClean Receives FDA Clearance appeared first on InvestorPlace.
InvestorPlace-股票市场新闻、股票建议和交易提示
空气净化(纳斯达克：AERC)股票受到投资者的极大关注，因为该公司昨天披露，美国食品和药物管理局(FDA)已将其空气净化系统指定为“二级医疗设备”。AERC股票昨天飙升100%，但今天早盘下跌超过15%。
AeroClean的空气净化设备Purgo被证明可以消除99.99%的空气中有害微生物，包括细菌、真菌和新冠肺炎等病毒，AeroClean解释说。该公司指出，它向“医疗机构、企业、接待场所和政府机构”销售“空气净化和空气消毒技术”。
尽管AERC的股票昨天大幅上涨，但其股票的换手价仍不到该公司52周高点117美元的4%。同样值得注意的是，AeroClean的企业价值为1950万美元，根据雅虎财经。
另一方面，在去年全年，该公司只创造了60万美元的收入。每股收益(EPS)为负0.69。
在过去的五天里，该公司股价上涨了88%，但今年到目前为止已经下跌了60%。AERC的股票目前处于低价股领域，约为每股4美元。
在本文发表之日，拉里·拉默并未(直接或间接)持有本文所述证券的任何头寸。本文表达的观点是作者的观点，受InvestorPlace.com和出版指南的约束。
关于细价股和低成交量股票： 除了最罕见的例外，Facebook InvestorPlace不会发布关于市值低于1亿美元或每天交易量低于10万股的公司的评论。这是因为这些“廉价股”经常是诈骗艺术家和市场操纵者的游乐场。如果我们确实发布了可能受我们的评论影响的低成交量股票的评论，我们要求 InvestorPlace.com《华尔街日报》的撰稿人披露了这一事实，并警告读者其中的风险。
阅读更多信息： 细价股-如何在不上当的情况下获利
在AeroClean获得FDA批准后，AERC股票的帖子首次出现在InvestorPlace上。
